Moderna, Pfizer raise bar for COVID-19 vaccines, may ward off competing candidates: GlobalData Read more
Ease of administration and dual protection can drive novel intranasal vaccine adoption: GlobalData Read more
Disappointing SOLIDARITY results for remdesivir likely due to trial differences and not the drug: GlobalData Read more
Antibodies against SARS-CoV-2 wane over time, suggesting immunity may be short-lived: GlobalData Read more